Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Ophthalmology
|
September 18, 2003
Outcome results in macular hole surgery: an evaluation of internal limiting membrane peeling with and without indocyanine green
Tom G Sheidow, Kevin J Blinder, Nancy Holekamp, et al.
Journal of Clinical Ultrasound : JCU
|
May 14, 2014
Sonographic diagnosis of primary hydatid disease in the breast: the scroll sign
Abhishek Jha, Prakhar Gupta, Shagufta Wahab, et al.
Chemosphere
|
January 19, 2024
Biphenyl-rGO composite room temperature gas sensor for enhanced amine sensing
Baliram Nadekar, Yogesh B Khollam, Shoyebmohamad F Shaikh, et al.
Medical Hypotheses
|
April 17, 2012
Lowering serum uric acid to prevent acute kidney injury
A Ahsan Ejaz, Bhagwan Dass, Ganesh Kambhampati, et al.
The New England Journal of Medicine
|
November 18, 2024
Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease
Barry Greenberg, Matthew Taylor, Eric Adler, et al.
Diagnostics (Basel, Switzerland)
|
April 23, 2022
Role of AS-OCT in Managing Corneal Disorders
Nidhi Gupta, Akhil Varshney, Muralidhar Ramappa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 9, 2013
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome
Patrick G Morris, Denise D Correa, Joachim Yahalom, et al.
Lancet (London, England)
|
January 15, 2013
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
John J Bissler, J Christopher Kingswood, Elżbieta Radzikowska, et al.
Science Translational Medicine
|
March 20, 2020
Systemic AAV9.LAMP2B injection reverses metabolic and physiologic multiorgan dysfunction in a murine model of Danon disease
Ana Maria Manso, Sherin I Hashem, Bradley C Nelson, et al.
Lancet (London, England)
|
November 20, 2012
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
David Neal Franz, Elena Belousova, Steven Sparagana, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Ophthalmology
|
September 18, 2003
Outcome results in macular hole surgery: an evaluation of internal limiting membrane peeling with and without indocyanine green
Tom G Sheidow, Kevin J Blinder, Nancy Holekamp, et al.
Journal of Clinical Ultrasound : JCU
|
May 14, 2014
Sonographic diagnosis of primary hydatid disease in the breast: the scroll sign
Abhishek Jha, Prakhar Gupta, Shagufta Wahab, et al.
Chemosphere
|
January 19, 2024
Biphenyl-rGO composite room temperature gas sensor for enhanced amine sensing
Baliram Nadekar, Yogesh B Khollam, Shoyebmohamad F Shaikh, et al.
Medical Hypotheses
|
April 17, 2012
Lowering serum uric acid to prevent acute kidney injury
A Ahsan Ejaz, Bhagwan Dass, Ganesh Kambhampati, et al.
The New England Journal of Medicine
|
November 18, 2024
Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease
Barry Greenberg, Matthew Taylor, Eric Adler, et al.
Diagnostics (Basel, Switzerland)
|
April 23, 2022
Role of AS-OCT in Managing Corneal Disorders
Nidhi Gupta, Akhil Varshney, Muralidhar Ramappa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 9, 2013
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome
Patrick G Morris, Denise D Correa, Joachim Yahalom, et al.
Lancet (London, England)
|
January 15, 2013
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
John J Bissler, J Christopher Kingswood, Elżbieta Radzikowska, et al.
Science Translational Medicine
|
March 20, 2020
Systemic AAV9.LAMP2B injection reverses metabolic and physiologic multiorgan dysfunction in a murine model of Danon disease
Ana Maria Manso, Sherin I Hashem, Bradley C Nelson, et al.
Lancet (London, England)
|
November 20, 2012
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
David Neal Franz, Elena Belousova, Steven Sparagana, et al.
Page
of 5